Interestingly, when URB597 was added during M1 polarization, the cells showed significantly lower levels of the M1-like markers CD80 and CD86 and higher levels of the signature M2-like marker CD206 (Figure 5B), suggesting that pharmacological inhibition of FAAH promoted an M1-to-M2 switch in AD. Here, CD86 is linked to Alzheimer disease.